{"id":7382,"date":"2023-11-15T09:42:49","date_gmt":"2023-11-15T09:42:49","guid":{"rendered":"https:\/\/www.dcberne.com\/?p=7382"},"modified":"2023-11-16T13:55:59","modified_gmt":"2023-11-16T13:55:59","slug":"dcb-open-innovation-challenge-mynerva-and-spotlight-aq-emerge-as-winners","status":"publish","type":"post","link":"https:\/\/www.dcberne.com\/en\/dcb-open-innovation-challenge-mynerva-and-spotlight-aq-emerge-as-winners\/","title":{"rendered":"DCB Open Innovation Challenge: MYNERVA and Spotlight-AQ Emerge as Winners"},"content":{"rendered":"

[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”80px||80px||false|false” custom_padding_tablet=”80px||80px||false|false” custom_padding_phone=”40px||80px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title title=”off” author=”off” date=”off” comments=”off” featured_image=”off” module_id=”meta-new” _builder_version=”4.19.4″ _module_preset=”default” title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Calibri Regular||||||||” meta_text_color=”RGBA(255,255,255,0)” meta_font_size=”10px” meta_line_height=”16px” custom_margin=”0px||0px||false|false” custom_padding=”0px||20px||false|false” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_post_title author=”off” date_format=”j \u00b7 M \u00b7 Y” comments=”off” featured_image=”off” _builder_version=”4.19.4″ _module_preset=”default” title_level=”h4″ title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Avant Regular||||||||” meta_text_color=”#000000″ meta_font_size=”14px” meta_line_height=”24px” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” title_font_size_tablet=”” title_font_size_phone=”42px” title_font_size_last_edited=”on|phone” title_line_height_tablet=”” title_line_height_phone=”48px” title_line_height_last_edited=”on|phone” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”20px” text_line_height=”24px” link_text_color=”#89BBE5″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

On November 9, this year’s DCB Start-Up Night and Award Ceremony of the Open Innovation Challenge 2023 took place. After an exciting evening of pitching, an international jury chose the winners of the third edition of the Open Innovation Challenge, which this year was split up into the two categories \u201cDiabetes Devices\u201d and \u201cDigital Diabetes\u201d.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/11\/SAE_5496-Kopie-scaled.jpg” title_text=”SAE_5496 Kopie” _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||40px||false|false” custom_padding_tablet=”0px||40px||false|false” custom_padding_phone=”||0px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”3_5,2_5″ module_id=”post-content” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px|0px|0px||false|false” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px|-439px|80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px|0px|0px||false|false” global_colors_info=”{}”]<\/p>\n

 <\/p>\n

Incredible 66 ideas were submitted to the Challenge, with three finalists in each category. These six finalists from the U.S., the U.K., Switzerland, Ireland, South Africa and France pitched their projects live on stage in Bern in front of 300 guests and an international jury. The first prizes of 100.000 USD in funding and in-kind support each went to MYNERVA (Switzerland) in the category Diabetes Devices and to Spotlight-AQ (U.K.) in the category Digital Diabetes.<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Avant Regular||on||||||” text_text_color=”#505358″ text_font_size=”30px” text_line_height=”40px” link_text_color=”#89BBE5″ background_image=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2022\/12\/Ellipse-24.png” background_size=”contain” background_position=”center_left” custom_margin=”0px||30px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”40px||40px||false|false” custom_padding_tablet=”40px||40px||false|false” custom_padding_phone=”0px||0px||false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”” text_font_size_phone=”24px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”” text_line_height_phone=”32px” text_line_height_last_edited=”on|phone” global_colors_info=”{}” custom_margin__hover_enabled=”off|hover” custom_margin__hover=”||48px||false|false”]<\/p>\n

“The DCB Open Innovation Challenge is our yearly highlight and our contribution to help the best startups in diabetes technology with a variety of services and sustainable connections. We are thrilled to continue our collaboration with all the finalists”,
<\/span><\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” min_height=”163.6px” global_colors_info=”{}”]<\/p>\n

says Ema Grabenweger, Innovation Manager and organiser of the DCB Start-Up Night.<\/span><\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Avant Regular||||||||” min_height=”58px” global_colors_info=”{}”]<\/p>\n

1st Place Diabetes Devices: MYNERVA<\/strong><\/h2>\n

[\/et_pb_text][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/11\/SAE_5368-Kopie.jpg” title_text=”SAE_5368 Kopie” show_bottom_space=”off” _builder_version=”4.23″ _module_preset=”default” width=”100%” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” custom_padding_tablet=”0px||16px||false|false” custom_padding_phone=”||8px||false|false” custom_padding_last_edited=”on|desktop” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_line_height=”20px” custom_margin=”0px||25px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

Derek Brandt (CEO DCB), Greta Ehlers (Business Development DCB), Greta Preatoni (CEO MYNERVA) and Maren Schinz (Innovation Manager DCB)<\/p>\n

[\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

MYNERVA<\/a>, winner of the category Diabetes Devices, is developing a unique wearable device for people living with diabetic neuropathy. The device restores the sense of touch and decreases pain through a non-invasive electrical nerve stimulation driven by AI algorithms.<\/p>\n

In her pitch, CEO Greta Preatoni emphasised the impact this can have on people’s quality of live, giving them back the ability to walk with more ease and without pain.<\/p>\n

[\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||40px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

1st Place Digital Diabetes: Spotlight-AQ<\/strong><\/h2>\n

[\/et_pb_text][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/11\/SAE_5432-1-Kopie.jpg” title_text=”SAE_5432-1 Kopie” show_bottom_space=”off” _builder_version=”4.23″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” custom_padding_tablet=”0px||16px||false|false” custom_padding_phone=”||8px||false|false” custom_padding_last_edited=”on|desktop” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_line_height=”20px” custom_margin=”0px||30px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

Ema Grabenweger (Innovation Manager DCB), Katharine Barnard (Spotlight-AQ) and Greta Ehlers (Business Development DCB)<\/p>\n

[\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Spotlight-AQ<\/a>, winner of the category Digital Diabetes, is on a mission to improve routine visits by helping people with diabetes to feel heard and doctors feel empowered to care. It is a novel validated infographic assessment platform highlighting user priority concerns and immediate mapped resources to meet those unmet needs.\u00a0<\/span><\/p>\n

In her pitch, CSO Katharine Barnard emphasised the role this can play within the constraints of existing healthcare systems and structures, benefiting people with diabetes, while reducing burnout among treating physicians.\u202f<\/span><\/span><\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

A Night of Innovation and Celebration<\/strong><\/h2>\n

[\/et_pb_text][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/11\/SAE_5496-scaled.jpg” title_text=”SAE_5496″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_line_height=”20px” custom_margin=”0px||45px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

All participating start-ups ready to celebrate with mentors, organisers and jury members<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

The DCB Start-Up Night marks the finale of the DCB Open Innovation Challenge and was celebrated accordingly. The two winners were awarded 100.000 USD each, consisting of 50.000 USD in funding and 50.000 USD in in-kind support (services provided by DCB and its partner network)<\/span>. The four remaining finalists received 20.000 USD each, consisting of 10.000 USD in funding and 10.000 USD in-kind support:<\/p>\n

[\/et_pb_text][et_pb_gallery gallery_ids=”7403,7405,7407,7409″ fullwidth=”on” _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_gallery][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_line_height=”20px” min_height=”36px” custom_margin=”0px||45px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

The four finalists pitching live on stage\u00a0<\/p>\n

[\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

Diabetes Devices<\/strong><\/h3>\n

Fada Medical<\/strong>\u00a0<\/span>(Ireland):<\/strong> Fada Medical has developed a technology that can extend an infusion site cannula\u2019s performance for up to 30 days to support long term insulin pump use for people with type 1 diabetes. They use a first-of-its-kind method to successfully delivery a therapeutic, such as insulin, into subcutaneous tissue and past any blockage that can occur from the foreign body response.<\/p>\n

Eclypia (France):<\/strong> Eclypia is developing a unique non-invasive sensing platform targeting health and wellness. Its first product is a non-invasive Continuous Glucose Monitoring device built on outstanding new and disruptive photonics technologies.<\/p>\n

\n

<\/strong><\/h3>\n

Digital Diabetes<\/strong><\/h3>\n

Africa Diabetes Chat (South Africa):<\/strong> Sweet Life has been creating easy-to-understand diabetes information for the community since it started in 2011, but over the past 3 years had a specific focus on testing out the most effective formats, language and languages (South Africa has 11 official languages). They are on a mission to solve diabetes education in South Africa and pave the way for it to be solved in all of Africa if the system is built in the right way. How? A WhatsApp chatbot.<\/span><\/p>\n

Gluroo (United States):<\/strong> Gluroo is a collaborative diabetes management app with a well-known usability: it\u2019s a chat app! The messaging group is your\u00a0<\/span>GluCrew<\/span>, and\u00a0<\/span>Gluroo<\/span>\u00a0provides high-quality integrations with CGMs and Pumps. Those integrations contribute to\u00a0<\/span>Gluroo\u2019s<\/span>\u00a0diabetes Event Log \u2013 the GEL.\u00a0 That GEL is shared and synchronized in real-time across all the devices so everyone can stay in sync, in real-time.<\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Avant Regular||on||||||” text_text_color=”#505358″ text_font_size=”30px” text_line_height=”40px” link_text_color=”#89BBE5″ background_image=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2022\/12\/Ellipse-24.png” background_size=”contain” background_position=”center_left” width=”100%” custom_margin=”0px||28px||false|false” custom_margin_tablet=”” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”40px||40px||false|false” custom_padding_tablet=”40px||40px||false|false” custom_padding_phone=”0px||0px||false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”” text_font_size_phone=”24px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”” text_line_height_phone=”32px” text_line_height_last_edited=”on|phone” global_colors_info=”{}” custom_margin__hover_enabled=”off|hover” custom_margin__hover=”||48px||false|false”]<\/p>\n

“We are especially proud of the engagement and growth of this year\u2019s teams and we are looking forward to continuing the work with one common goal \u2013 to make life better for people with diabetes”,\u00a0<\/span><\/span><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

says Maren Schinz, DCB Innovation Manager and responsible for the Open Innovation Challenge 2023.<\/span><\/span><\/p>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”30px” text_line_height=”36px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” global_colors_info=”{}”]<\/p>\n

About the DCB Open Innovation Challenge<\/h3>\n

[\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px|-454px|80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px|0px|0px||false|false” global_colors_info=”{}”]<\/p>\n

After the initial launch in 2021, the DCB Open Innovation Challenge took place for the third time this year. The aim of the Challenge is to promote innovative, international projects in the field of diabetes management. With a total prize money of 280.000 USD, the DCB Open Innovation Challenge is one of the world\u2019s most generous international awards in the area of diabetes. Applications are open to start-ups, medical and research professionals, and individuals.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”|||64px|false|false” custom_padding_tablet=”|||0px|false|false” custom_padding_phone=”||40px|0px|false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}” custom_padding__hover_enabled=”off|desktop”][et_pb_divider show_divider=”off” _builder_version=”4.19.4″ _module_preset=”default” min_height=”196.8px” custom_margin=”19px||||false|false” custom_padding=”||0px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/11\/87c987de-1366-4b48-b518-533886864264.jpg” title_text=”87c987de-1366-4b48-b518-533886864264″ show_bottom_space=”off” _builder_version=”4.23″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” custom_padding_tablet=”0px||16px||false|false” custom_padding_phone=”||8px||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_line_height=”20px” custom_margin=”0px||52px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n

Jury, Start-Ups and DCB Organisers celebrating the wins<\/p>\n

[\/et_pb_text][et_pb_divider show_divider=”off” _builder_version=”4.19.4″ _module_preset=”default” min_height=”1000px” custom_margin=”-500px||||false|false” custom_padding=”||0px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_divider show_divider=”off” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”403px||||false|false” global_colors_info=”{}”][\/et_pb_divider][et_pb_divider show_divider=”off” _builder_version=”4.19.4″ _module_preset=”default” min_height=”482.8px” custom_margin=”400px||||false|false” custom_padding=”||25px|||” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.19.4″ _module_preset=”default” background_color=”#FAFAFA” custom_margin=”0px||120px||false|false” custom_margin_tablet=”0px||120px||false|false” custom_margin_phone=”||80px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”80px||44px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”42px” text_line_height=”48px” custom_margin=”0px||0px||false|false” custom_padding=”0px||40px||false|false” custom_padding_tablet=”0px||40px||false|false” custom_padding_phone=”||16px||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

More recent news<\/p>\n

[\/et_pb_text][et_pb_blog fullwidth=”off” posts_number=”3″ include_categories=”33,34,35″ meta_date=”j \u00b7 M \u00b7 Y” excerpt_length=”120″ show_author=”off” show_pagination=”off” masonry_tile_background_color=”RGBA(255,255,255,0)” module_class=”dcb-news” _builder_version=”4.19.4″ _module_preset=”default” header_font=”Avant Regular||||||||” header_text_color=”#000000″ header_font_size=”20px” header_line_height=”24px” body_font=”Calibri Regular||||||||” body_text_color=”#505358″ body_font_size=”16px” body_line_height=”22px” meta_font=”Calibri Regular||||||||” meta_font_size=”10px” meta_line_height=”16px” pagination_text_color=”#89BBE5″ pagination_font_size=”18px” pagination_line_height=”24px” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false” meta_line_height_tablet=”16px” meta_line_height_phone=”16px” meta_line_height_last_edited=”on|phone” custom_css_title=”margin-bottom: 8px !important;” custom_css_post_meta=”text-transform: uppercase;” border_width_all=”0px” global_colors_info=”{}” header_text_color__hover_enabled=”on|hover” header_text_color__hover=”#89BBE5″ custom_css_featured_image_last_edited=”off|phone” custom_css_title_last_edited=”off|phone” custom_css_title_tablet=”margin-bottom: 8px;” custom_css_title_phone=”margin-bottom: 16px;” custom_css_content_last_edited=”on|phone” custom_css_content_phone=”margin-bottom: 24px;” custom_css_post_meta_last_edited=”on|phone” custom_css_post_meta_tablet=”text-transform: uppercase;” custom_css_post_meta_phone=”text-transform: uppercase;”][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.19.4″ _module_preset=”default” min_height=”252.2px” custom_margin=”0px||-1px||false|false” custom_padding=”0px||32px||false|false” border_width_top=”0.5px” border_color_top=”#505358″ global_module=”283″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” module_alignment=”center” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”30px” text_line_height=”36px” text_orientation=”center” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” global_colors_info=”{}”]<\/p>\n

Recent News<\/span><\/p>\n

[\/et_pb_text][et_pb_blog fullwidth=”off” posts_number=”3″ include_categories=”33,34,35″ meta_date=”j \u00b7 M \u00b7 Y” excerpt_length=”120″ show_author=”off” show_pagination=”off” masonry_tile_background_color=”RGBA(255,255,255,0)” module_class=”dcb-news” _builder_version=”4.19.4″ _module_preset=”default” header_font=”Avant Regular||||||||” header_text_color=”#000000″ header_font_size=”20px” header_line_height=”24px” body_font=”Calibri Regular||||||||” body_text_color=”#505358″ body_font_size=”16px” body_line_height=”22px” meta_font=”Calibri Regular||||||||” meta_font_size=”10px” meta_line_height=”16px” pagination_text_color=”#89BBE5″ pagination_font_size=”18px” pagination_line_height=”24px” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false” meta_line_height_tablet=”16px” meta_line_height_phone=”16px” meta_line_height_last_edited=”on|phone” custom_css_title=”margin-bottom: 8px !important;” custom_css_post_meta=”text-transform: uppercase;” border_width_all=”0px” global_colors_info=”{}” header_text_color__hover_enabled=”on|hover” header_text_color__hover=”#89BBE5″ custom_css_featured_image_last_edited=”off|phone” custom_css_title_last_edited=”off|phone” custom_css_title_tablet=”margin-bottom: 8px;” custom_css_title_phone=”margin-bottom: 16px;” custom_css_content_last_edited=”on|phone” custom_css_content_phone=”margin-bottom: 24px;” custom_css_post_meta_last_edited=”on|phone” custom_css_post_meta_tablet=”text-transform: uppercase;” custom_css_post_meta_phone=”text-transform: uppercase;”][\/et_pb_blog][et_pb_code _builder_version=”4.21.0″ _module_preset=”default” text_orientation=”center” width=”50%” module_alignment=”center” min_height=”255px” global_colors_info=”{}”]<\/p>\n

<\/p>\n
<\/p>\n
<\/p>\n

Subscribe to our newsletter to receive the latest news<\/h2>\n

<\/p>\n

*<\/span> indicates required<\/div>\n

<\/p>\n

\t